https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-ekterly
Drug Trials Snapshots: EKTERLY | FDA
Drug Trials Snapshots: EKTERLY
drug trials snapshotsekterlyfda
https://www.tga.gov.au/resources/auspmd/ekterly-sebetralstat
Ekterly (sebetralstat) | Therapeutic Goods Administration (TGA)
Mar 20, 2026 - Ekterly (sebetralstat) has been approved for hereditary angioedema (HAE) attacks caused by C1 inhibitor deficiency or dysfunction, in patients aged 12 years...
ekterlysebetralstattherapeuticgoodsadministration
https://www.tga.gov.au/resources/prescription-medicines-registrations/ekterly-jace-pharma-pty-ltd
EKTERLY (JACE Pharma Pty Ltd) | Therapeutic Goods Administration (TGA)
May 7, 2026 - Active ingredients: sebetralstat.
pty ltdekterlyjacepharmatherapeutic
https://www.medicines.org.uk/emc/product/101475/pil
Ekterly 300 mg film-coated tablet - Patient Information Leaflet (PIL) - (emc) | 101475
Ekterly 300 mg film-coated tablet - Patient Information Leaflet (PIL) by KalVista Pharmaceuticals Limited
patient information leaflet300 mgfilm coated
https://www.tga.gov.au/resources/artg/462847
EKTERLY sebetralstat 300 mg film coated tablets blister pack (462847) | Therapeutic Goods...
Dec 11, 2025 - Australian Register of Therapeutic Goods (ARTG) information for EKTERLY sebetralstat 300 mg film coated tablets blister pack.
300 mgfilm coated
https://www.goodrx.com/ekterly/what-is
Ekterly (sebetralstat): Uses, Side Effects, Dosage & Reviews
Learn about Ekterly (sebetralstat) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
side effectsekterlysebetralstatusesdosage